Shock therapy making a comeback

Jan 14, 2008

Electroshock therapy is coming back into favor as a treatment for depression in the United States.

In the last 25 years, the number of U.S. patients undergoing the treatment -- formally known as electroconvulsive therapy -- has tripled to about 100,000, Te Raleigh (N.C.) News & Observer reported Sunday.

The treatment faces a stigma, the newspaper said. Some view it as a form of torture, while others argue it causes permanent mental damage.

The American Psychiatric Association last month agreed to a new examination of literature on the practice.

Even among doctors who use it, there is disagreement about its effects, the newspaper said. Some feel it causes almost no problems, while others feel it can cause problems, but they are outweighed by the good done in some patients.

Both doctors and patients who use it say it is the only treatment that works for some suffering from severe depression.

"It's becoming a treatment of next resort instead of a treatment of last resort," said Dr. Michael A. Hill, a psychiatrist at University of North Carolina Hospitals, who administers the therapy.

Copyright 2008 by United Press International

Explore further: Amgen misses 1Q views as higher costs cut profit

add to favorites email to friend print save as pdf

Related Stories

Slow pokes: Acupuncture helps hypothermic turtles

May 21, 2013

Two endangered sea turtles that are shells of their former selves after getting stranded on Cape Cod during a cold spell are getting some help easing back into the wild—from an acupuncturist.

Recommended for you

Amgen misses 1Q views as higher costs cut profit

9 hours ago

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

18 hours ago

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

Roopie
not rated yet Jan 21, 2008
I appreciated your article printed in local paper - Carroll County Times, Westminster, MD today. In my late teens and early 20's I experienced major depression. ECT was the only treatment that brought relief. However, I was aware that this needed to be followed with extensive psychotherapy as well. I had short term memory loss, but at age 45 returned to college to obtain my BA and MS. I am currently employed at the same psychiatric Center where I was treated. Now being there as LCPC and Chaplain. I hope this article brings hope to others.

More news stories

Volitional control from optical signals

(Medical Xpress)—In their quest to build better BMIs, or brain-machine-interfaces, researchers have recently begun to look closer at the sub-threshold activity of neurons. The reason for this trend is that ...

Neuroimaging: Live from inside the cell

A novel imaging technique provides insights into the role of redox signaling and reactive oxygen species in living neurons, in real time. Scientists of the Technische Universität München and the Ludwig-Maximilians-Universität ...

Mantis shrimp stronger than airplanes

(Phys.org) —Inspired by the fist-like club of a mantis shrimp, a team of researchers led by University of California, Riverside, in collaboration with University of Southern California and Purdue University, ...